Human polyspecific immunoglobulin for therapeutic use induces p21/WAF-1 and Bcl-2, which may be responsible for G1 arrest and long-term survival

Simple item page
dc.contributor.authorEkberg, C.
dc.contributor.authorNordström, E.
dc.contributor.authorSkansen-Saphir, U.
dc.contributor.authorMansouri, M.
dc.contributor.authorRaqib, R.
dc.contributor.authorSundqvist, V-A.
dc.contributor.authorFernandez, C.
dc.date.accessioned2015-01-07T02:51:43Z
dc.date.available2015-01-07T02:51:43Z
dc.date.issued2001
dc.identifier.otherhttp://dspace.icddrb.org/jspui/handle/123456789/5607
dc.identifier.urihttp://hdl.handle.net/123456789/5607
dc.language.isoen
dc.sourceICDDR,B Institutional Repository
dc.subjectImmunoglobulins, intravenous
dc.subjectLeukocytes, mononuclear
dc.subjectAntibody specificity
dc.subjectProto-oncogene proteins c-bcl-2
dc.subjectCyclin-dependent kinase inhibitor p21
dc.subjectAzure stains
dc.titleHuman polyspecific immunoglobulin for therapeutic use induces p21/WAF-1 and Bcl-2, which may be responsible for G1 arrest and long-term survival
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2001-HumImmunol-215-EkbergC.pdf
Size:
11.51 KB
Format:
Adobe Portable Document Format
Download

Collections

A. Original papers